Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.580
+0.080 (3.20%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
105
Market Cap
183.26M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 154.90M |
| Vaxart | 148.20M |
| Whitehawk Therapeutics | 14.38M |
| Caribou Biosciences | 11.16M |
| Tonix Pharmaceuticals Holding | 10.30M |
| Cartesian Therapeutics | 1.09M |
| Molecular Partners AG | 856.30K |
| SAB Biotherapeutics | 114.70K |
NKTX News
- 10 days ago - Nkarta to Participate in March Investor Conferences - GlobeNewsWire
- 3 months ago - Nkarta to Participate in Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha
- 4 months ago - Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - Nkarta to Participate in November Investor Conferences - GlobeNewsWire
- 4 months ago - Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - GlobeNewsWire
- 6 months ago - Nkarta to Participate in a September Investor Conference - GlobeNewsWire
- 7 months ago - Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire